News for Certara, Inc. (CERT)

On July 3, 2025, Certara (CERT) received a new analyst rating from Morgan Stanley. The financial services company has assigned an "Equal-Weight" rating to Certa

The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial intelligence and genomic medicine are delivering innovative therapies with significant potential. Here are 10 under-the-radar healthcare stocks that could be great buys for your portfolio.

Shares of Certara Inc (CERT) surged 4.79% in mid-day trading on Jun 26. The stock reached an intraday high of $11.44, before settling at $11.38, up from its

Shares of Certara Inc (CERT) surged 3.14% in mid-day trading on Jun 10. The stock reached an intraday high of $12.33, before settling at $12.14, up from its

Shares of Certara Inc (CERT) surged 4.54% in mid-day trading on Jun 4. The stock reached an intraday high of $11.99, before settling at $11.98, up from its

[url="]Schrödinger[/url], Inc. (Nasdaq: SDGR) today announced the expansion of its leadership team with the appointment of Mannix Aklian as executive vice pre

Schrodinger has expanded its executive team by appointing Mannix Aklian as the executive vice president and chief commercial officer. With over 25 years of expe

PR NewswireVANCOUVER, BC, May 23, 2025 Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc.VANCOUVER, BC, May 23, 2025 /PRNewswire/ --

Shares of Certara Inc (CERT) fell 4.79% in mid-day trading on May 21. The stock reached an intraday low of $11.07, before recovering slightly to $11.13, dow

In recent developments, Certara (CERT) has received a favorable upgrade from the well-known investment bank, Barclays. The analyst behind this move, Luke Sergot

In a recent announcement, investment firm JMP Securities has reiterated its "Market Perform" rating for Certara (CERT). This reaffirmation comes from analyst Co

Revenue: $106 million, 10% year-over-year growth.Bookings: $118.2 million, 12% year-over-year growth.Software Revenue: $46.4 million, 18% year-over-year growth

Market Analysis by covering: Novartis AG ADR, The Lovesac Company, Schrodinger Inc, Certara Inc. Read 's Market Analysis on Investing.com

As of April 15, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading...

U.S. stocks were lower, with the Dow Jones index dipping over 250 points on Friday. Shares of Fastenal Company FAST rose sharply during Thursday's session foll...

Shares of argenx SE ARGX rose sharply in today's pre-market trading after the company announced the FDA approval of VYVGART Hytrulo prefilled syringe for self-i...

**media[582597]**

We recently compiled a list of the 10 Cash-Rich Small Cap Stocks To Invest In According To Analysts. In this article, we are going to take a look at where Certara, Inc.

Small-cap stocks in the US have been under pressure, with the Russell small cap index falling 10% from its November highs as of January 2025.